Cargando…

PS142. Ketamine is effective in an animal model of treatment resistant depression

Detalles Bibliográficos
Autores principales:	Pereira, Vitor Silva, Joca, Sâmia R.L., Wegener, Gregers
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616738/ http://dx.doi.org/10.1093/ijnp/pyw043.142

Ejemplares similares

PS137. Evidence that Cannabidiol Induces Acute Antidepressant-Like Efects in Different Animal Models
por: Joca, Samia, et al.
Publicado: (2016)

Sex and Estrous Cycle Are Not Mediators of S-Ketamine’s Rapid-Antidepressant Behavioral Effects in a Genetic Rat Model of Depression
por: Arjmand, Shokouh, et al.
Publicado: (2023)

PS111. A comparative study of fluoxetine and ketamine on quinolinic acid: An in vivo study in rats
por: Eskelund, Amanda, et al.
Publicado: (2016)

PS125. Functional and morphological changes induced by ketamine in the hippocampus
por: Treccani, Giulia, et al.
Publicado: (2016)

PS202. The regulation of orexins and their cognate receptors in two distinct rat models of depression and effects of treatments
por: Harpøth, Astrid, et al.
Publicado: (2016)

PS133. The role of Toxoplasma gondii in depression and anxiety - gene-environment interactions in the FSL rat model
por: Bay-Richter, Cecilie, et al.
Publicado: (2016)

S-Ketamine Rapidly Reverses Synaptic and Vascular Deficits of Hippocampus in Genetic Animal Model of Depression
por: Ardalan, Maryam, et al.
Publicado: (2016)

PS103. Search for biomarkers for ketamine response from changes of cytokines in the patients with treatment resistant depression
por: Su, Tung-Ping, et al.
Publicado: (2016)

P2X7 Receptor Signaling in Stress and Depression
por: Ribeiro, Deidiane Elisa, et al.
Publicado: (2019)

PS101. Oral Ketamine for Treatment Resistant Major Depression – A double blind randomized controlled trial
por: Domany, Yoav, et al.
Publicado: (2016)

‘Long-COVID’ - a neuroinflammatory disease
por: Schou, Thor, et al.
Publicado: (2022)

How effective are ketamine or esketamine in treatment-resistant depression?
por: Veluri, N., et al.
Publicado: (2021)

Psychiatric and neuropsychiatric sequelae of COVID-19 – A systematic review
por: Schou, Thor Mertz, et al.
Publicado: (2021)

ZL006, a small molecule inhibitor of PSD-95/nNOS interaction, does not induce antidepressant-like effects in two genetically predisposed rat models of depression and control animals
por: Tillmann, Sandra, et al.
Publicado: (2017)

Rethinking treatment-resistant depression to quasi-tenacious depression
por: Arjmand, Shokouh, et al.
Publicado: (2023)

S142. RESTING STATE NETWORKS ALTERATION IN BIPOLAR DEPRESSION
por: Mingoia, Gianluca, et al.
Publicado: (2018)

Reduced P2X receptor levels are associated with antidepressant effect in the learned helplessness model
por: Ribeiro, Deidiane Elisa, et al.
Publicado: (2019)

PS87. An update on prediction of treatment outcome in treatment resistant depression
por: Kautzky, Alexander, et al.
Publicado: (2016)

PS193. MicroRNAs as biomarkers for treatment-resistant depression
por: Gururajan, A, et al.
Publicado: (2016)

Administration of galacto-oligosaccharide prebiotics in the Flinders Sensitive Line animal model of depression
por: Bannach-Brown, Alexandra, et al.
Publicado: (2019)

Subcutaneous ketamine in the treatment of depression and suicide risk: case report.
por: Cigognini, M. A., et al.
Publicado: (2023)

Strain-, Sex-, and Time-Dependent Antidepressant-like Effects of Cannabidiol
por: Silote, Gabriela P., et al.
Publicado: (2021)

PS118. Single administration of ketamine and Pregnenolone-Methyl-Ether (3ß-Methoxy-Pregnenolone) has antidepressant efficacy in a preclinical model of treatment resistant depression: identification of a plasma biomarker of pharmacological efficacy
por: Jack, Prenderville, et al.
Publicado: (2016)

Therapy group following a Ketamine treatment – a case report of a patient with resistant depression
por: Yaniv, H., et al.
Publicado: (2022)

PS109. The antidepressant-like effect induced by caloric restriction: possible involvement of orexin-A.
por: Stanquini, LA, et al.
Publicado: (2016)

PM363. The effect of Ketamine: Gunn rat as a Schizophrenia animal model
por: Hayashida, Maiko, et al.
Publicado: (2016)

Esketamine/ketamine for treatment-resistant depression
por: Lacerda, Acioly L.T.
Publicado: (2020)

The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
por: Hashimoto, Kenji
Publicado: (2014)

PS128. Ketamine R(-) and S(+) Pharmacological Actions; Together or Separate Rapid Acting Antidepressants
por: Domino, Edward F.
Publicado: (2016)

PS135. Effects of the mineralocorticoid receptor antagonist spironolactone in a treatment-resistant model of depression in female rats
por: Hlavacova, N, et al.
Publicado: (2016)

Antidepressant Effects of NSAIDs in Rodent Models of Depression—A Systematic Review
por: Bay-Richter, Cecilie, et al.
Publicado: (2022)

S-Ketamine in the treatment of depressive emergencies: a cases series of patients in a suicidal crisis
por: Baune, B., et al.
Publicado: (2022)

Clinical Efficacy of Ketamine for Treatment-resistant Depression
por: Bratsos, Sosipatros, et al.
Publicado: (2019)

Magnesium in Ketamine Administration in Treatment-Resistant Depression
por: Górska, Natalia, et al.
Publicado: (2021)

S-Ketamine Mediates Its Acute and Sustained Antidepressant-Like Activity through a 5-HT(1B) Receptor Dependent Mechanism in a Genetic Rat Model of Depression
por: du Jardin, Kristian G., et al.
Publicado: (2018)

F11. TRANSLATIONAL STUDY OF GRIN1, GRIN2A AND 2B GENE EXPRESSION IN PATIENTS WITH SCHIZOPHRENIA AND ANIMAL MODELS
por: Marcelino, Loureiro Camila, et al.
Publicado: (2018)

PS106. Nicotinic acetylcholine receptor antagonists for treatment-resistant depression: A meta-analysis.
por: Wang, Hee Ryung, et al.
Publicado: (2016)

14.2 STUCTURED RISK ASSESSMENT IN PSYCHIATRY
por: Fazel, Seena, et al.
Publicado: (2018)

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
por: Gałuszko-Węgielnik, Maria, et al.
Publicado: (2023)

PS222. Ketamine Exerts a Prolonged Reduction in Suicidal Ideation Independent of its Antidepressant Effects
por: Phillips, Jennifer L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_21e26utitme7d4thvca7f9ns44